GRAND RAPIDS, Mich. , July 14, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused...
Refinancing Existing Debt with Significantly Improved Terms
GRAND RAPIDS, Mich. , May 26, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused...
Shoulder Innovations (NYSE:SI) reported a sharp increase in first-quarter revenue and raised its full-year sales outlook, citing new surgeon adoption, higher utilization among existing customers and progress...
Generates First Quarter Net Revenue Growth of 65% Year-Over-Year
Latest Addition to I-Series Product Line Follows a Successful Limited Market Release and FDA Clearance of Additional Fracture Indications
GRAND RAPIDS, Mich. , April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming...
Fourth Quarter Net Revenue Growth Accelerates to 65% Year-Over- Year
GRAND RAPIDS, Mich. , March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming...
GRAND RAPIDS, Mich. , Feb. 18, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming...